Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 20/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | CCR5 | P51681 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL995030 | 1.00 | CCR1 (1.00) | CCR1CHRM2CCR5 | |
| SCHEMBL30059121 | 1.00 | CCR1 (1.00) | CCR1CHRM2CCR5 | |
| SCHEMBL993794 | 0.94 | CCR1 (0.90) | CCR1CHRM2CCR5 | |
| SCHEMBL18776064 | 0.93 | CCR1 (0.87) | CCR1CHRM2CCR5 | |
| SCHEMBL9910989 | 0.91 | CCR1 (0.87) | CCR1CHRM2CCR5 | |
| SCHEMBL993584 | 0.91 | CCR1 (0.83) | CCR1CHRM2CCR5 | |
| SCHEMBL6807717 | 0.90 | CCR1 (0.82) | CCR1CHRM2CCR5 | |
| SCHEMBL6251094 | 0.90 | CCR1 (0.82) | CCR1CHRM2CCR5 | |
| SCHEMBL6248473 | 0.90 | CCR1 (0.82) | CCR1CHRM2CCR5 | |
| SCHEMBL6249065 | 0.90 | CCR1 (0.81) | CCR1CHRM2CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250026848-A1 | IDENTIFICATION OF PATHOGENIC IMMUNE CELL SUBSETS IN CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2025-01-23 | — | — | US | claimed |
| WO-2023023269-A1 | IDENTIFICATION OF PATHOGENIC IMMUNE CELL SUBSETS IN CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-02-23 | — | — | WO | claimed |
| EP-4608403-A1 | MODULATORS AND USES THEREOF | Hadasit Medical Research Services&Development Ltd. (IL) | 2025-09-03 | — | — | EP | disclosed |
| US-20250213647-A1 | CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE | UNIVERSITY OF SOUTH FLORIDA | 2025-07-03 | — | — | US | disclosed |
| US-20250026848-A1 | IDENTIFICATION OF PATHOGENIC IMMUNE CELL SUBSETS IN CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2025-01-23 | — | — | US | disclosed |
| WO-2024089691-A1 | MODULATORS AND USES THEREOF | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD (IL) | 2024-05-02 | — | — | WO | disclosed |
| WO-2023192319-A1 | CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE | UNIVERSITY OF SOUTH FLORIDA (US) | 2023-10-05 | — | — | WO | disclosed |
| EP-4143235-A1 | METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM INFECTIONS, INCLUDING COVID-19, BY INHIBITING CCR5/CCL5 INTERACTION | IncellDx, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| WO-2023023269-A1 | IDENTIFICATION OF PATHOGENIC IMMUNE CELL SUBSETS IN CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-02-23 | — | — | WO | disclosed |
| US-11364305-B2 | Nanoparticle conjugates and uses thereof | UNIVERSITY OF MIAMI (US) | 2022-06-21 | — | — | US | disclosed |